
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
TETRAN CRISPR/Cas9 KO Plasmid (h) | sc-411436 | 20 µg | $397.00 |
MFSD10 encodes TETRAN, a multi-pass membrane protein thought to participate in solute transport-related processes and membrane homeostasis, consistent with membership in the major facilitator superfamily. As a putative transporter-like factor, TETRAN is of interest for studies of endomembrane trafficking, organelle function, and cellular metabolic adaptation, where changes in small-molecule flux can modulate stress signaling and downstream transcriptional programs. Altered MFSD10 expression has been reported in transcriptomic datasets across multiple disease contexts, supporting investigation of its contribution to dysregulated metabolism and cell-state transitions. Defining TETRAN function can help clarify how membrane transport networks influence proliferation, survival, and differentiation phenotypes in human cells.
TETRAN CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the MFSD10 gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the MFSD10 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the MFSD10 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish TETRAN protein expression.
This CRISPR knockout system enables efficient generation of MFSD10-deficient cell models for investigation of TETRAN signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.